Clinical Trials Browser

Phase 2 × Adebrelimab × apatinib × Clear all

NCT07353684 2026-01-20

Adebrelimab, Apatinib & SOX for Conversion Therapy in Advanced Gastric/GEJ Cancer

Phase 2 Recruiting

Gastrointestinal

Adebrelimab